SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent - BioSpace

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent  BioSpace

Published: Jul 23, 2019. North America, Europe and Japan trial seeks approval for the US and Japanese markets. TIANJIN, China, July 23, 2019 /PRNewswire/ ...



Comments

Popular posts from this blog

Keto crotch: Is it real and how to treat it

Shave your pubic hair if you want, but not at these times

What is Ivermectin, the drug Goa will give to all adults to combat Covid-19 - India Today